Financhill
Sell
8

SPRO Quote, Financials, Valuation and Earnings

Last price:
$0.95
Seasonality move :
10.44%
Day range:
$0.95 - $0.99
52-week range:
$0.95 - $1.89
Dividend yield:
0%
P/E ratio:
12.00x
P/S ratio:
0.58x
P/B ratio:
0.80x
Volume:
329.6K
Avg. volume:
242.9K
1-year change:
-28.91%
Market cap:
$52.3M
Revenue:
$96.7M
EPS (TTM):
$0.08

Earnings Data

Next earnings date for SPRO
Mar 13
2025
Most recent earnings per share
-$0.32
Beat by $0.04
(Nov 14/2024)
Consensus Estimate
-$0.36
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SPRO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/13/2025 Q4 $4.1M -- -- -$0.41 --
11/14/2024 Q3 $7.7M $7.8M -$0.32 -$0.36 $0.04
08/05/2024 Q2 $3.3M $6M -$0.33 -$0.38 $0.05
05/15/2024 Q1 $21.5M $4.2M -$0.24 -$0.07 -$0.18
03/13/2024 Q4 $18.6M $71.8M $0.97 -$0.10 $1.07
11/13/2023 Q3 -- -- -$0.06 -$0.03 -$0.03
08/10/2023 Q2 -- -- -$0.23 -$0.38 $0.15
05/11/2023 Q1 -- -- -$0.25 -$0.26 $0.01
03/30/2023 Q4 -- -- $0.55 -$0.34 $0.89
11/14/2022 Q3 -- -- -$0.33 -$0.24 -$0.09
08/10/2022 Q2 -- -- -$0.87 -$0.93 $0.06
05/16/2022 Q1 -- -- -$1.01 -$0.96 -$0.06
03/31/2022 Q4 -- -- -$0.92 -$0.75 -$0.17
11/10/2021 Q3 -- -- -$0.70 -$0.66 -$0.04
08/05/2021 Q2 -- -- -$0.63 -$0.75 $0.12
05/06/2021 Q1 -- -- -$0.66 -$0.63 -$0.03
03/11/2021 Q4 -- -- -$0.68 -$0.74 $0.06
11/05/2020 Q3 -- -- -$0.86 -$0.89 $0.03
08/06/2020 Q2 -- -- -$0.85 -$1.13 $0.28
05/08/2020 Q1 -- -- -$1.22 -$1.38 $0.16
03/16/2020 Q4 -- -- -$1.32 -$1.08 -$0.24
11/04/2019 Q3 -- -- -$0.95 -$0.85 -$0.10
08/08/2019 Q2 -- -- -$0.74 -$0.86 $0.12
05/09/2019 Q1 -- -- -$0.29 -$0.77 $0.48
03/14/2019 Q4 -- -- -$0.60 -$0.75 $0.15
11/08/2018 Q3 -- -- -$0.60 -$0.63 $0.03
08/09/2018 Q2 -- -- -$0.69 -$0.78 $0.09
04/02/2018 Q1 -- -- -$0.74 -$1.20 $0.46
12/31/2017 Q4 -- -- -$1.59 -$1.22 -$0.37
12/14/2017 Q3 -- -- -$36.02 -$35.07 -$0.95
08/06/2015 Q2 -- -- $0.10 -- --
05/05/2015 Q1 -- -- -- -- --
03/05/2015 Q4 -- -- -- -- --

Spero Therapeutics Earnings Questions

  • How Much did Spero Therapeutics Generate in Revenue Last Quarter?

    Spero Therapeutics reported $7.8M worth of top line sales in its most recent quarter.

  • Did Spero Therapeutics Beat Earnings Last Quarter?

    Spero Therapeutics announced earnings per share of -$0.32 which represents a beat of analyst forecast a -$0.36 per share.

  • Is Spero Therapeutics Profitable?

    Spero Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Spero Therapeutics EPS Next Year?

    Spero Therapeutics's earnings are forecast to decrease from $0.43 per share to -$0.78 per share next year representing a decrease of -36.99%.

  • When is Spero Therapeutics's Earnings Date?

    Spero Therapeutics's next earnings date is March 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 3.23% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.78% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock